Relationship between Bell's Palsy and Previous Statin Use: A Case/Non-Case Study

Int J Environ Res Public Health. 2020 Nov 13;17(22):8408. doi: 10.3390/ijerph17228408.

Abstract

We intended to determine the relationship between previous statin use and Bell's palsy in a large study population receiving statins for the past 2 years. The Korean National Health Insurance Service-Health Screening Cohort data from 2002 to 2015 were collected. Participants with Bell's palsy (n = 3203) were matched with participants without Bell's palsy (n = 12,812). The number of days of previous statin use for 2 years before the onset of Bell's palsy was analyzed using conditional logistic regression. Subgroups of age, sex, obesity, smoking, alcohol consumption, total cholesterol, and blood pressure were analyzed for any association between Bell's palsy and prior statin use. The Bell's palsy group reported greater statin use than the non-Bell's palsy group (84.6 (standard deviation, SD = 201.7) vs. 74.4(SD = 189.4), p = 0.009). Previous statin use was associated with Bell's palsy in the crude model (95% confidence intervals = 1.03-1.19, p = 0.006). However, this relationship disappeared when the possible covariates were adjusted for in model 2. All subgroups showed no increased odds for Bell's palsy in previous statin users. We did not find an association between Bell's palsy and previous statin use in this Korean population aged ≥40 years.

Keywords: Bell’s palsy; case/non-case Bell’s palsy study; cohort study; hydroxymethylglutaryl-CoA reductase inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alcohol Drinking
  • Bell Palsy* / epidemiology
  • Cohort Studies
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Male
  • Middle Aged
  • Republic of Korea / epidemiology
  • Risk Factors
  • Smoking

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors